PfizerPFE
PFE logo
Fair Value
US$28
Share price31 Dec
US$25.1510.2% undervalued intrinsic discount
Loading
1Y5.63%
7D1.33%

Pfizer is about resilience and dividend yield

Author hasn't set their bio yet

Published
31 Dec 25
Views
583
Not Invested

Fair Value vs Share Price

US$28
vs US$25.1510.2% undervalued intrinsic discount
PastFuture0101b20142017202020232025202620292030Revenue US$100.1bEarnings US$15.6b
9.8%
Revenue growth
15.6%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Pfizer

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Good value average dividend payer.

Market capUS$143.9b
PB1.6x
Estimated Growth-3.7%
Dividend Yield6.8%
Full analysis

CEO & management

Albert Bourla
CEO
6.2yrs
CEO Tenure

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.